Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 21;18(Suppl 1):20.
doi: 10.1186/s12865-017-0204-1.

Experimental Validation of the RATE Tool for Inferring HLA Restrictions of T Cell Epitopes

Free PMC article

Experimental Validation of the RATE Tool for Inferring HLA Restrictions of T Cell Epitopes

Sinu Paul et al. BMC Immunol. .
Free PMC article


Background: The RATE tool was recently developed to computationally infer the HLA restriction of given epitopes from immune response data of HLA typed subjects without additional cumbersome experimentation.

Results: Here, RATE was validated using experimentally defined restriction data from a set of 191 tuberculosis-derived epitopes and 63 healthy individuals with MTB infection from the Western Cape Region of South Africa. Using this experimental dataset, the parameters utilized by the RATE tool to infer restriction were optimized, which included relative frequency (RF) of the subjects responding to a given epitope and expressing a given allele as compared to the general test population and the associated p-value in a Fisher's exact test. We also examined the potential for further optimization based on the predicted binding affinity of epitopes to potential restricting HLA alleles, and the absolute number of individuals expressing a given allele and responding to the specific epitope. Different statistical measures, including Matthew's correlation coefficient, accuracy, sensitivity and specificity were used to evaluate performance of RATE as a function of these criteria. Based on our results we recommend selection of HLA restrictions with cutoffs of p-value < 0.01 and RF ≥ 1.3. The usefulness of the tool was demonstrated by inferring new HLA restrictions for epitope sets where restrictions could not be experimentally determined due to lack of necessary cell lines and for an additional data set related to recognition of pollen derived epitopes from allergic patients.

Conclusions: Experimental data sets were used to validate RATE tool and the parameters used by the RATE tool to infer restriction were optimized. New HLA restrictions were identified using the optimized RATE tool.

Keywords: Epitope; HLA association; HLA restriction; MHC; RATE; T cell.


Fig. 1
Fig. 1
Illustrative description of the two sets of ELISPOT data derived from MTB epitopes and how they were used. The left panel shows the response data obtained when reactivity of each of the 191 peptides was determined in a set of 87 HLA typed donors and was used to infer restrictions by the RATE approach. The right panel shows the HLA restriction of the same 191 peptides in 63 donors determined experimentally using HLA transfected cell lines. This data was then screened and used for validation of RATE by comparing with RATE results from the first data set

Similar articles

See all similar articles

Cited by 5 articles


    1. Nepom GT. MHC class II tetramers. J Immunol. 2012;188(6):2477–2482. doi: 10.4049/jimmunol.1102398. - DOI - PMC - PubMed
    1. Davis MM, Altman JD, Newell EW. Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis. Nat Rev Immunol. 2011;11(8):551–558. doi: 10.1038/nri3020. - DOI - PMC - PubMed
    1. Newell EW, Davis MM. Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol. 2014;32(2):149–157. doi: 10.1038/nbt.2783. - DOI - PMC - PubMed
    1. Tiwari JL, Terasaki PI. HLA and disease associations. New York: Springer Science & Business Media; 2012.
    1. Coffey LL, Mertens E, Brehin A, Fernandez-Garcia MD, Amara A, Després P, Sakuntabhai A. Human genetic determinants of dengue virus susceptibility. Microb Infect. 2009;11(2):143–156. doi: 10.1016/j.micinf.2008.12.006. - DOI - PubMed

Publication types

LinkOut - more resources